SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-21-124581
Filing Date
2021-10-08
Accepted
2021-10-08 15:52:03
Documents
4
Period of Report
2021-11-10

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2129502d1_pre14a.htm PRE 14A 330252
2 GRAPHIC tm2129502d1_pre14aimg01.jpg GRAPHIC 4116
3 GRAPHIC proxycrd_001.jpg GRAPHIC 175569
4 GRAPHIC proxycrd_002.jpg GRAPHIC 102993
  Complete submission text file 0001104659-21-124581.txt   714601
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-15070 | Film No.: 211315280
SIC: 2834 Pharmaceutical Preparations